Cover ImageSALE


Global Therapeutic Vaccines Market 2014-2018

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 298803
出版日期 內容資訊 英文 54 Pages
Back to Top
全球治療用疫苗市場預測 Global Therapeutic Vaccines Market 2014-2018
出版日期: 2014年03月28日 內容資訊: 英文 54 Pages



第1章 摘要整理

第2章 簡稱清單

第3章 調查範圍

  • 市場概要
  • 主要的產品

第4章 市場調查手法

  • 市場調查流程
  • 調查手法

第5章 簡介

第6章 市場形勢

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第7章 地理區分

第8章 主要國家

  • 美國

第9章 購買標準

第10章 市場成長因素

第11章 成長因素與其影響

第12章 市場課題

第13章 成長因素與課題的影響

第14章 市場趨勢

第15章 趨勢與其影響

第16章 開發平台分析

第17章 業者情勢

  • 競爭模式
    • 主要消息
    • M&A
  • 其他卓越供應商

第18章 主要供應商分析

  • Agenus Inc.
  • Bavarian Nordic A/S
  • Dendreon Corp.
  • GlaxoSmithKline plc
  • Novartis International AG

第19章 其他報告

Product Code: IRTNTR3441

About Therapeutic Vaccines

A therapeutic vaccine is a biological combination developed to improve immunity by inducing an attack against a diseased cell or tissue. This differs from prophylactic vaccines, which are administered to an individual with a disease in order to induce a defense mechanism. There are two approved cancer therapeutic vaccines on the market; Provenge and Oncophage. Additionally, a large number of therapeutic vaccines are under clinical development and are expected to be approved for use during the forecast period.

TechNavio's analysts forecast the Global Therapeutic Vaccines market to grow at a CAGR of 62.81 percent over the period 2013-2018.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Therapeutic Vaccine market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of various therapeutic vaccines available in the market.

TechNavio's report, the Global Therapeutic Vaccines Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Therapeutic Vaccines market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • EMEA
  • APAC

Key Vendors

  • Agenus Inc.
  • Bavarian Nordic A/S.
  • Dendreon Corp.
  • GlaxoSmithKline plc
  • Novartis International AG

Other Prominent Vendors

  • AFFiRiS AG.
  • Argos Therapeutics Inc.
  • Celldex Therapeutics Inc.
  • CEL-SCI Corp.
  • Cytos Biotechnology AG
  • GlobeImmune Inc.
  • NewLink Genetics Corp.
  • NovaRx Corp.
  • Oncothyreon Inc.
  • TVAX Biomedical Inc.
  • TapImmune Inc.
  • Vical Inc.
  • Vaccinogen Inc.

Market Driver

  • Increase in Incidence of Cancer, Infectious Diseases, and Physiological Disorders
  • Ongoing Development of a Large Number of Therapeutic Vaccines

Market Challenge

  • Stringent Regulations
  • Adverse Side Effects of Therapeutic Vaccines

Market Trend

  • Improved Understanding of Immunology and Immunotherapy
  • Increase in Mergers and Acquisitions

Key questions answered in this report:

  • What will the market size be in 2018 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. Market Overview
  • 06.2. Market Size and Forecast
  • 06.3. Five Forces Analysis

07. Geographical Segmentation

08. Key Leading Countries

  • 08.1. USA

09. Buying Criteria

10. Market Growth Drivers

11. Drivers and their Impact

12. Market Challenges

13. Impact of Drivers and Challenges

14. Market Trends

15. Trends and their Impact

16. Pipeline Analysis

17. Vendor Landscape

  • 17.1. Competitive Scenario
    • 17.1.1. Key News
    • 17.1.2. Mergers and Acquisitions
  • 17.2. Other Prominent Vendors

18. Key Vendor Analysis

  • 18.1. Agenus Inc.
    • 18.1.1. Business Overview
    • 18.1.2. Key Information
    • 18.1.3. SWOT Analysis
  • 18.2. Bavarian Nordic A/S
    • 18.2.1. Business Overview
    • 18.2.2. Business Segmentation
    • 18.2.3. Key Information
    • 18.2.4. SWOT Analysis
  • 18.3. Dendreon Corp.
    • 18.3.1. Business Overview
    • 18.3.2. Key Information
    • 18.3.3. SWOT Analysis
  • 18.4. GlaxoSmithKline plc
    • 18.4.1. Business Overview
    • 18.4.2. Business Segmentation
    • 18.4.3. Key Information
    • 18.4.4. SWOT Analysis
  • 18.5. Novartis International AG
    • 18.5.1. Business Overview
    • 18.5.2. Business Segmentation
    • 18.5.3. Key Information
    • 18.5.4. SWOT AnalysisOther Reports in the Series

List of Exhibits:

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Global Therapeutic Vaccines Market 2013-2018 (US$ billion)
  • Exhibit 3: Global Therapeutic Vaccines Market by Geographical Segmentation 2013
  • Exhibit 4: Segmentation of Therapeutic Vaccines under Clinical Trial, by Disease 2013
  • Exhibit 5: Segmentation of Therapeutic Vaccines under Clinical Trial by Type of Cancer 2013
  • Exhibit 6: Segmentation of Therapeutic Vaccines under Clinical Trial by Type of Tropical Infectious Disease 2013
  • Exhibit 7: Segmentation of Therapeutic Vaccines under Clinical Trial, By Physiological Disorders 2013
  • Exhibit 8: Late Stage Pipeline Analysis of Therapeutic Vaccines 2013
  • Exhibit 9: Business Segmentation of Bavarian Nordic A/S
  • Exhibit 10: Business Segmentation of GlaxoSmithKline plc
  • Exhibit 11: Business Segmentation of Novartis International AG
Back to Top